| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -1,049,342 | 100% | $40.48 | -$42,480,762 |
| Net | -8 | -1,049,342 | -100% | -$42,480,762 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher Anzalone | Chief Executive Officer, Director | $251,799,942 | -$31,593,209 | -11% | 02 Jan 2026 |
| Patrick O'Brien | Coo | $36,342,471 | -$3,123,349 | -7.9% | 06 Jan 2026 |
| James Hamilton | Chief Medical Officer | $16,395,566 | -$3,809,661 | -19% | 06 Jan 2026 |
| Daniel Joseph Apel | Chief Financial Officer | $11,697,935 | 06 Jan 2026 | ||
| Kenneth Myszkowski | Chief Financial Officer | $8,967,476 | 04 Jan 2025 | ||
| Javier San | Chief Medical Officer | $7,417,833 | 04 Jan 2024 | ||
| MICHAEL PERRY | Director | $4,977,736 | -$991,738 | -17% | 16 Dec 2025 |
| James Hassard | Chief Commercial Officer | $3,951,878 | 22 Jun 2021 | ||
| Tracie Oliver | Chief Commercial Officer | $3,213,265 | 02 Jul 2024 | ||
| Mauro Ferrari | Director | $3,097,782 | -$1,020,513 | -25% | 26 Dec 2025 |
| DOUGLAS B. GIVEN | Director | $2,736,641 | 16 Dec 2024 | ||
| William D. Waddill | Director | $2,626,418 | -$566,038 | -18% | 19 Dec 2025 |
| Hongbo Lu | Director | $2,224,021 | 16 Dec 2025 | ||
| DOUGLAS S. INGRAM | Director | $1,869,396 | 16 Dec 2025 | ||
| Victoria Vakiener | Director | $1,851,113 | -$679,491 | -27% | 19 Dec 2025 |
| ADEOYE OLUKOTUN | Director | $1,763,620 | -$696,762 | -28% | 19 Dec 2025 |
| Marianne De Backer | Director | $1,168,448 | 10 Jan 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|